Triple-negative breast cancers or in short TNBCs are regarded as aggressive types of breast cancer and are the product of impaired expression of progesterone and estrogen receptors as well as human growth factor receptor 2 (Bianchini et al., 2016). The gene discussed is ESR1; the disease is breast carcinoma.